Knutsson M, Salomonsson T, Durmo F, Johansson E, Seidemo A, Latt J
Front Neurosci. 2025; 19:1533799.
PMID: 39975970
PMC: 11836003.
DOI: 10.3389/fnins.2025.1533799.
Bai J, He M, Gao E, Yang G, Zhang C, Yang H
Eur Radiol. 2024; 34(10):6616-6628.
PMID: 38485749
PMC: 11399163.
DOI: 10.1007/s00330-024-10686-8.
Ezzati S, Salib S, Balasubramaniam M, Aboud O
Int J Mol Sci. 2024; 25(4).
PMID: 38396993
PMC: 10889328.
DOI: 10.3390/ijms25042316.
Alrosan A, Heilat G, Al Subeh Z, Alrosan K, Alrousan A, Abu-Safieh A
Anticancer Drugs. 2023; 34(9):985-994.
PMID: 37466094
PMC: 10501357.
DOI: 10.1097/CAD.0000000000001533.
Nowakowski A, Lahijanian Z, Panet-Raymond V, Siegel P, Petrecca K, Maleki F
Neurooncol Adv. 2022; 4(1):vdac141.
PMID: 36284932
PMC: 9583687.
DOI: 10.1093/noajnl/vdac141.
Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis.
Pons-Escoda A, Garcia-Ruiz A, Naval-Baudin P, Grussu F, Sanchez Fernandez J, Simo A
Eur Radiol. 2022; 32(6):3705-3715.
PMID: 35103827
DOI: 10.1007/s00330-021-08498-1.
Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the Brain.
Leung S, Foley O, Chapel D, da Silva A, Nucci M, Muto M
Oncologist. 2021; 26(12):e2102-e2109.
PMID: 34355460
PMC: 8649002.
DOI: 10.1002/onco.13927.
Stratifying Brain Tumour Histological Sub-Types: The Application of ATR-FTIR Serum Spectroscopy in Secondary Care.
Cameron J, Rinaldi C, Butler H, Hegarty M, Brennan P, Jenkinson M
Cancers (Basel). 2020; 12(7).
PMID: 32605100
PMC: 7408619.
DOI: 10.3390/cancers12071710.
Histopathological Profile of Brain Tumors: A 12-year Retrospective Study from Madinah, Saudi Arabia.
Mohammed A, Hamdan A, Homoud A
Asian J Neurosurg. 2020; 14(4):1106-1111.
PMID: 31903347
PMC: 6896618.
DOI: 10.4103/ajns.AJNS_185_19.
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
Boire A, Brandsma D, Brastianos P, Le Rhun E, Ahluwalia M, Junck L
Neuro Oncol. 2019; 21(5):571-584.
PMID: 30668804
PMC: 6502489.
DOI: 10.1093/neuonc/noz012.
The "pool sign" of metastatic adenocarcinoma.
Bhatt A, Lin E, Almast J
Neuroradiology. 2018; 60(9):983-985.
PMID: 30069615
DOI: 10.1007/s00234-018-2069-2.
A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models.
Yagiz K, Rodriguez-Aguirre M, Espinoza F, Montellano T, Mendoza D, Mitchell L
Mol Ther Oncolytics. 2018; 8:14-26.
PMID: 29322091
PMC: 5751967.
DOI: 10.1016/j.omto.2017.12.001.
Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.
Zhang J, Liu H, Tong H, Wang S, Yang Y, Liu G
Contrast Media Mol Imaging. 2017; 2017:7064120.
PMID: 29097933
PMC: 5612612.
DOI: 10.1155/2017/7064120.
Could new reconstruction CT techniques challenge MRI for the detection of brain metastases in the context of initial lung cancer staging?.
Millon D, Byl D, Collard P, Cambier S, Van Maanen A, Vlassenbroek A
Eur Radiol. 2017; 28(2):770-779.
PMID: 28856413
DOI: 10.1007/s00330-017-5021-7.
Surgery for CNS Tumors in the Brazilian National Health Care System.
Pontes L, Shafaee M, Haaland B, Lopes G
J Glob Oncol. 2017; 3(2):157-161.
PMID: 28717753
PMC: 5493277.
DOI: 10.1200/JGO.2016.004911.
Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.
Jung B, Arevalo-Perez J, Lyo J, Holodny A, Karimi S, Young R
J Neuroimaging. 2015; 26(2):240-6.
PMID: 26235208
PMC: 4753138.
DOI: 10.1111/jon.12281.
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.
Tsao M, Rades D, Wirth A, Lo S, Danielson B, Gaspar L
Pract Radiat Oncol. 2015; 2(3):210-225.
PMID: 25925626
PMC: 3808749.
DOI: 10.1016/j.prro.2011.12.004.
Liquid biopsies in patients with diffuse glioma.
Best M, Sol N, Zijl S, Reijneveld J, Wesseling P, Wurdinger T
Acta Neuropathol. 2015; 129(6):849-65.
PMID: 25720744
PMC: 4436687.
DOI: 10.1007/s00401-015-1399-y.
Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases.
Thavarajah N, Ray S, Bedard G, Zhang L, Cella D, Wong E
CNS Oncol. 2015; 4(1):11-23.
PMID: 25586422
PMC: 6093024.
DOI: 10.2217/cns.14.49.
Esophageal cancer presenting as a brain metastasis: A case report.
Spallone A, Izzo C
Oncol Lett. 2013; 6(3):722-724.
PMID: 24137398
PMC: 3789036.
DOI: 10.3892/ol.2013.1436.